The FNAIT Journey: Learning

Newly diagnosed? Read the latest insights on what to expect next.

Diagnosis Seekers
Newly Diagnosed
On Your Way
Long-Term Living

Treatments FDA fast tracks J&J’s nipocalimab to reduce risk of FNAIT

First page

Previous page Page 1 … Page 23 Page 24 Page 25 Last page

Learn more about FNAIT

Sign up for the latest news, perspectives, and information about FNAIT.

Subscribe

Your news and information resource for fetal and neonatal alloimmune thrombocytopenia

Search for:

News
Features
Voices
Education
Contribute
About
Staff

Part of the Haymarket Medical Network

Rare Disease Companion (RDC) is a network of news and information websites that supports people living with rare diseases. Through accurate, authentic, and compassionate news coverage, feature-length articles, and patient-friendly educational material, RDC provides insights into living with rare diseases at every point along the patient journey.

Copyright © 2026 Haymarket Media, Inc. All Rights Reserved. This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media’s Privacy Policy and Terms & Conditions.

The FNAIT Journey: Learning

Treatments FDA fast tracks J&J’s nipocalimab to reduce risk of FNAIT

Learn more about FNAIT

Sign up for the latest news, perspectives, and information about FNAIT.